DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratoryconfirmed previous dengue infection and living in endemic areas.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5HbQuWt
No comments:
Post a Comment